Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: Forebrain

doi:10.1016/0306-4522(87)90006-6

Neuroscience

Volume 20, Issue 1, January 1987, Pages 65-107

https://doi.org/10.1016/0306-4522(87)90006-6 Get rights and content

Abstract

The distribution of muscarinic cholinergic receptors in the human forebrain and cerebellum was studied in detail by quantitative autoradiography using N-[³H]methylscopolamine as a ligand. Only postmortem tissue from patients free of neurological diseases was used in this study. The highest densities of muscarinic cholinergic receptors were found in the striatum, olfactory tubercle and tuberal nuclei of the hypothalamus. Intermediate to high densities were observed in the amygdala, hippocampal formation and cerebral cortex. In the thalamus muscarinic cholinergic receptors were heterogeneously distributed, with densities ranging from very low to intermediate or high. N-[³H]Methylscopolamine binding was low in the hypothalamus, globus pallidus and basal forebrain nuclei and very low in the cerebellum and white matter tracts.

The localization of the putative muscarinic cholinergic receptors subtypes M₁ and M₂ was analysed in parallel using carbachol and pirenzepine at a single concentration to partially inhibit N-[³H]methylscopolamine binding. Mixed populations of both subtypes were found in all regions. M₁ sites were largely predominant in the basal ganglia, amygdala and hippocampus and constituted the majority of muscarinic cholinergic receptors in the cerebral cortex. M₂ sites were preferentially localized in the diencephalon, basal forebrain and cerebellum. In some areas such as the striatum and substantia innominata there was a tendency to lower densities of muscarinic cholinergic receptors with increasing age. In general, we observed a slight decrease in M₂ sites in elderly cases. Muscarinic cholinergic receptor concentrations seemed to be reduced following longer postmortem periods. The distribution of acetylcholinesterase was also studied using histochemical methods and compared with the localization of muscarinic cholinergic receptors and other cholinergic markers.

The correlation between the presence of muscarinic cholinergic receptors and the involvement of cholinergic mechanisms in the function of specific brain areas is discussed. Their implication in neurological diseases is also reviewed.

Reference (179)

BartusR.T.
Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: effects of concurrent administration of physostigmine and methyl phenidate with scopolamine
Pharmac. Biochem. Behav.
(1978)
BartusR.T. et al.
Memory deficits in aged Cebus monkeys and facilitation with central cholinomimetics
Neurobiol. Aging
(1980)
Ben-AriY. et al.
Regional distribution of choline acetyltransferase and acetylcholinesterase within the amygdaloid complex and stria terminalis system
Brain Res.
(1977)
BiglV. et al.
Cholinergic projections from the basal forebrain to frontal, parietal, temporal, occipital and cingulate cortices: a combined fluorescent tracer and acetylcholinesterase analysis
Brain Res. Bull.
(1982)
BlockG.A. et al.
Properties and regional distribution of nicotinic cholinergic receptors in the rat hypothalamus
Brain Res.
(1981)
BraakH. et al.
Neurontal types in the basolateral amygdaloid nucleus of man
Brain Res. Bull.
(1983)
CaulfieldM.P. et al.
Cortical muscarinic receptor subtypes and Alzheimer's disease
Lancet
(1982)
ClarkeP.B.S. et al.
Autoradiographic distribution of nicotine receptors in rat brain
Brain Res.
(1984)
Corte´sR. et al.
Quantitative light microscopic autroadiographic localization of cholinergic muscarinic receptors in human brain: brainstem
Neuroscience
(1984)
Corte´sR. et al.
Muscarinic cholinergic receptor subtypes in the rat brain. I. Quantitative autoradiographic studies
Brain Res.
(1986)

Corte´sR. et al.

Muscarinic cholinergic receptor subtypes in the human brain: II. Quantitative autoradiographic studies

Brain Res.

(1986)

DaviesP.

Neurotransmitter-related enzymes in senile dementia of the Alzheimer type

Brain Res.

(1979)

DaviesP. et al.

Selective loss of central cholinergic neurons in Alzheimer's disease

Lancet

(1976)

De BellerocheJ. et al.

Analysis of muscarinic receptor concentration and subtypes following lesion of rat substantia innominata

Brain Res.

(1985)

EckensteinF. et al.

Cholinergic neurons in the rat cerebral cortex demonstrated by immunohistochemical localization of choline acetyltransferase

Neurosci. Lett.

(1983)

EnnaS.J. et al.

Alterations of brain neurotransmitter receptor binding in Huntington's chorea

Brain Res.

(1976)

FibigerH.C.

The organization and some projections of cholinergic neurons of the mammalian forebrain

Brain Res. Rev.

(1982)

GearyW.A. et al.

Regional tritium quenching in quantitative autoradiography of the central nervous system

Brain Res.

(1985)

GearyW.A. et al.

Quantitative film autoradiography for tritium: methodological consideration

Brain Res.

(1985)

GermanD.C. et al.

Immunohistochemical staining of cholinergic neurons in the human brain using a polyclonal antibody to human choline acetyltransferase

Neurosci. Lett.

(1985)

HammerR. et al.

Muscarinic receptor subtypes: M₁ and M₂ biochemical and functional characterization

Life Sci.

(1982)

HedreenJ.C. et al.

Immunocytochemical identification of cholinergic neurons in the monkey central nervous system using monoclonal antibodies against choline acetyltransferase

Neurosci. Lett.

(1983)

HenkeH. et al.

Cholinergic enzymes in neocortex, hippocampus and basal forebrain of nonneurological and senile dementia of Alzheimer-type patients

Brain Res.

(1983)

HerkenhamM. et al.

Quantitative receptor autoradiographic tissue defatting eliminates differential self-absorption of tritrium radiation in gray and white matter of brain

Brain Res.

(1984)

HooverD.P. et al.

A mapping of the distribution of acetylcholine, choline acetyltransferase and acetylcholinesterase in discrete areas of rat brain

Brain Res.

(1978)

HouserC.R. et al.

Organization and morphological characteristics of cholinergic neurons: an immunocytochemical study with monoclonal antibody to choline acetyltransferase

Brain Res.

(1983)

HuntS. et al.

Some observations on the binding patterns of α-bungarotoxin in the central nervous system of the rat

Brain Res.

(1978)

IshiiT. et al.

A comparative histochemical mapping of the distribution of acetylcholinesterase and nicotinamide adenine dinucleotide-diaphorase activities in the human brain

Int. Rev. Neurobiol.

(1967)

KellyP.H. et al.

Decrease of neocortical choline acetyltransferase after lesion of the globus pallidus in the rat

Expl Neurol.

(1978)

KobayashiR.M. et al.

Regional distribution of muscarinic cholinergic receptors in rat brain

Brain Res.

(1978)

Ko¨hlerC. et al.

The cytoarchitecture, histochemistry and projections of the tubero-mamillary nucleus of the rat

Neuroscience

(1985)

KuharM.J. et al.

Localization of cholinergic muscarinic receptors in rat brain by light microscopic radioautography

Brain Res.

(1976)

KuharM.J.

Autoradiographic localization of drug and neurotransmitter receptors in the brain

Trends Neurosci.

(1981)

KuharM.J. et al.

Quantitative receptor mapping by autoradiography: some current technical problems

Trends Neurosci.

(1985)

KwakS. et al.

Tridimensional distribution of markers of neurotransmitters within the “accumbens area” of normal human brains

Neuroscience

(1984)

LangW. et al.

Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer type patients

Brain Res.

(1983)

LehmannJ. et al.

Acetylcholinesterase and the cholinergic neuron

Life Sci.

(1979)

LehmannJ. et al.

Regional heterogeneity of choline acetyltransferase activity in primate neocortex

Brain Res.

(1984)

LeveyA.I. et al.

Choline acetyltransferase-immunoreactive neurons intrinsic to rodent cortex and distinction from acetylcholinesterase positive neurons

Neuroscience

(1984)

MesulamM.-M. et al.

Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6)

Neuroscience

(1983)

MesulamM.-M. et al.

Atlas of cholinergic neurons in the forebrain and upper brainstem of the macaque based on monoclonal choline acetyltransferase immunohistochemistry and acetylcholinesterase histochemistry

Neuroscience

(1984)

MesulamM.-M. et al.

Regional variations in cortical cholinergic innervation: chemoarchitectonics of acetylcholinesterase-containing fibers in the macaque brain

Brain Res.

(1984)

NagaiT. et al.

Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls

Neurosci. Lett.

(1983)

NagaiT. et al.

Immunohistochemical staining of the human forebrain with monoclonal antibody to human choline acetyltransferase

Brain Res.

(1983)

AquiloniusS.M. et al.

Regional distribution of choline acetyltransferase in the human brain: changes in Huntington's chorea

J. Neurol. Neurosurg. Psychiat.

(1975)

ArmstrongD.M. et al.

Distribution of cholinergic neurons in rat brain: demonstrated by the immunocytochemical localization of choline acetyltransferase

J. comp. Neurol.

(1983)

BartusR.T.

Physostigmine and recent memory: effects in young and aged nonhuman primates

Science

(1979)

BartusR.T. et al.

The cholinergic hypothesis of geriatric memory dysfunction

Science

(1982)

BellerS.A. et al.

Efficacy of oral physostigmine in primary degenerative dementia. A double-blind study of response to different dose level

Psychopharmacology

(1985)

BirdsallN.J.M. et al.

The binding of agonists to brain muscarinic receptors

Molec. Pharmac.

(1978)

Cited by (107)

Cortical layers: Cyto-, myelo-, receptor- and synaptic architecture in human cortical areas
2019, NeuroImage
Citation Excerpt :
However, the typical six-layered pattern of cytoarchitecture cannot be found in most receptor types; consequently, the borders between receptor-dense and receptor-sparse layers do not consistently coincide with the borders of layers detectable in cyto- or myeloarchitectonic studies. Rather, receptor densities seem to show a type- and region-specific layering pattern (Amunts et al., 2010; Caspers et al., 2013, 2015; Cortés et al., 1986, 1987; Eickhoff et al., 2007, 2008; Hoyer et al., 1986a,b; Jansen et al., 1989; Morosan et al., 2005; Palomero-Gallagher et al., 2008, 2009, 2013, 2015, Pazos et al., 1987a,b; Scheperjans et al., 2005a,b; Vogt et al., 2013; Zilles et al., 2002a, 2004, 2015a; Zilles and Amunts, 2009; Zilles and Palomero-Gallagher, 2001, 2017). Since most receptors are found on dendrites and not on the cell bodies of pyramidal cells and interneurons (Kooijmans et al., 2014), and the dendrites of pyramidal cells cross many cytoarchitectonically defined layers, the layering pattern of receptors is not bound to a single layer of cell bodies (cytoarchitecture) or myelinated nerve fibers (myeloarchitecture).
Cortical layers have classically been identified by their distinctive and prevailing cell types and sizes, as well as the packing densities of cell bodies or myelinated fibers. The densities of multiple receptors for classical neurotransmitters also vary across the depth of the cortical ribbon, and thus determine the neurochemical properties of cyto- and myeloarchitectonic layers. However, a systematic comparison of the correlations between these histologically definable layers and the laminar distribution of transmitter receptors is currently lacking. We here analyze the densities of 17 different receptors of various transmitter systems in the layers of eight cytoarchitectonically identified, functionally (motor, sensory, multimodal) and hierarchically (primary and secondary sensory, association) distinct areas of the human cerebral cortex. Maxima of receptor densities are found in different layers when comparing different cortical regions, i.e. laminar receptor densities demonstrate differences in receptorarchitecture between isocortical areas, notably between motor and primary sensory cortices, specifically the primary visual and somatosensory cortices, as well as between allocortical and isocortical areas. Moreover, considerable differences are found between cytoarchitectonical and receptor architectonical laminar patterns. Whereas the borders of cyto- and myeloarchitectonic layers are well comparable, the laminar profiles of receptor densities rarely coincide with the histologically defined borders of layers. Instead, highest densities of most receptors are found where the synaptic density is maximal, i.e. in the supragranular layers, particularly in layers II–III. The entorhinal cortex as an example of the allocortex shows a peculiar laminar organization, which largely deviates from that of all the other cortical areas analyzed here.
Cyto- and receptor architectonic mapping of the human brain
2018, Handbook of Clinical Neurology
Citation Excerpt :
Nicotinic α4β2 receptors reach highest densities in the primary visual, auditory, and somatosensory cortices as well as in the motor, posterior cingulate, and entorhinal cortices (Fig. 24.5J). More detailed descriptions concerning the regional differences and laminar distribution patterns of muscarinic and nicotinic acetylcholine receptors can be found in the literature (Cortés and Palacios, 1986; Cortés et al., 1986, 1987; Lin et al., 1986; Araujo et al., 1988; Vanderheyden et al., 1990; Perry et al., 1992, 1993; Zilles, 1992, 2005; Court et al., 1993, 1997; Lange et al., 1993; Zilles et al., 1995, 1996, 2002a, b, 2003, 2004, 2015a; Geyer et al., 1997; Rodriguez-Puertas et al., 1997; Sihver et al., 1998; Crook et al., 2000, 2001; Marutle et al., 2001; Zilles and Palomero-Gallagher, 2001; Piggott et al., 2002; Morosan et al., 2004; Pimlott et al., 2004; Matsumoto et al., 2005; Scheperjans et al., 2005a, b; Eickhoff et al., 2007a, b, 2008; Palomero-Gallagher et al., 2008, 2009a, b, 2013; Palomero-Gallagher and Zilles, 2009; Zilles and Amunts, 2009, 2010; Amunts et al., 2010; Caspers et al., 2013c, 2015). Densities of α2-adrenoceptors in the cerebral cortex are generally lower than those of α1-adrenoceptors (Figs. 24.5K and L), with the notable exception of primary sensory areas (Scheperjans et al., 2005b; Eickhoff et al., 2007a; Zilles et al., 2015a; Zilles and Palomero-Gallagher, 2016), but are higher than those of β-adrenoceptors (Sastre et al., 2001).
Mapping of the human brain is more than the generation of an atlas-based parcellation of brain regions using histologic or histochemical criteria. It is the attempt to provide a topographically informed model of the structural and functional organization of the brain. To achieve this goal a multimodal atlas of the detailed microscopic and neurochemical structure of the brain must be registered to a stereotaxic reference space or brain, which also serves as reference for topographic assignment of functional data, e.g., functional magnet resonance imaging, electroencephalography, or magnetoencephalography, as well as metabolic imaging, e.g., positron emission tomography. Although classic maps remain pioneering steps, they do not match recent concepts of the functional organization in many regions, and suffer from methodic drawbacks.
This chapter provides a summary of the recent status of human brain mapping, which is based on multimodal approaches integrating results of quantitative cyto- and receptor architectonic studies with focus on the cerebral cortex in a widely used reference brain. Descriptions of the methods for observer-independent and statistically testable cytoarchitectonic parcellations, quantitative multireceptor mapping, and registration to the reference brain, including the concept of probability maps and a toolbox for using the maps in functional neuroimaging studies, are provided.
Relationship between muscarinic M<inf>1</inf> receptor binding and cognition in medication-free subjects with psychosis
2018, NeuroImage: Clinical
Citation Excerpt :
Moreover, regular treatment of Parkinson's disease with muscarinic receptor antagonists frequently induces cognitive deficits as an unwanted side effect (Xiang et al., 2012). These effects are to be predominantly mediated by the muscarinic M1 receptor subtype due to its high expression in critical regions for cognition (i.e., dorsolateral prefrontal cortex (DLPFC), hippocampus and striatum) (Cortes et al., 1987). Evidence for lower M1 receptor expression in psychotic disorders comes from post-mortem studies showing reduced expression rates of the M1 receptor subtype in the DLPFC.
It is still unclear which underlying mechanisms are involved in cognitive deficits of psychotic disorders. Pro-cognitive effects of muscarinic M₁ receptor agonists suggest alterations in M₁ receptor functioning may modulate these symptoms. Post mortem studies in patients with schizophrenia have shown significantly reduced M₁ receptor expression rates in the dorsolateral prefrontal cortex (DLPFC) compared to controls. To date no in-vivo examinations of M₁ receptor binding in relation to cognitive impairments have been done. As cognitive deficits have similar course and prognostic relevance across psychotic disorders, the current study assessed M₁ receptor binding in the DLPFC and hippocampus in relation to cognitive functioning.
Muscarinic M₁ receptor binding potential (BP_ND) was measured using ¹²³I-IDEX, single photon emission computed tomography (SPECT) in 30 medication-free subjects diagnosed with a psychotic disorder. A computerized neuropsychological test battery was used to assess cognition, and the positive and negative syndrome scale (PANSS) to assess severity of psychotic symptoms.
Assessment of cognitive domains showed that lower M₁ BP_ND in the DLPFC was related to overall lower performance in verbal learning and memory. In addition, lower M₁ BP_ND in the DLPFC was related to greater negative symptom severity. Lastly, lower M₁ BP_ND in the hippocampus was related to worse delayed recognition of verbal memory.
This is the first study to show that variation in M₁ receptors in the DLPFC is related to cognitive and negative symptom outcome in psychotic disorders. The M₁ receptor may be an important biomarker in biological stratification of patients with psychotic disorders.
Comparative Analysis of Receptor Types That Identify Primary Cortical Sensory Areas
2016, Evolution of Nervous Systems: Second Edition
Primary sensory cortical areas display a typical cytoarchitecture. It is largely unknown whether they present a common molecular organization segregating them from other cortical areas. We analyzed multiple receptors in primary visual (V1), somatosensory (S1), and auditory (A1) areas of primate (human, macaque, marmoset, galago), scandentia (tree shrew), rodent, afrotherian (tenrec), and marsupial (opossum) brains. Exceptionally high M₂ receptor expression occurs in these areas in all eutherian brains. Very high GABA_A, α₂, and 5-HT₂ densities exist only in human, macaque, and marmoset V1, and in human and macaque S1. The 5-HT₂ receptor reaches very high concentrations in human, macaque, and marmoset A1.
Transmitter Receptor Distribution in the Human Brain
2015, Brain Mapping: An Encyclopedic Reference
Transmitter receptors are key molecules of signal processing in the brain. They occur at different densities between different cortical regions and layers, as well as subcortical nuclei. The differences enable mapping of these structures based on the density of a single or multiple receptors in each structure. We summarize data of selected receptor types of classical transmitter systems in the human cerebral cortex, cerebellum, hippocampus, amygdala, basal ganglia, and thalamus. A short review of developmental and age-related changes is also provided. Finally, we show the relevance of multireceptor analyses (receptor fingerprints) for the characterization of functional systems at the molecular level.
Human Brain Imaging of Acetylcholine Receptors
2014, Imaging of the Human Brain in Health and Disease
The neurotransmitter acetylcholine (ACh) is widely distributed within the central nervous system (CNS) and is involved in a number of important processes, including roles in sensory and motor processing, sleep, nociception, mood, stress response, attention, arousal, memory, motivation, and reward. The actions of ACh are mediated through the muscarinic ACh receptor (mAChR) and nicotinic ACh receptor (nAChR). Postmortem studies indicated marked changes in the mAChR and nAChR in the brain associated with several neurological disorders. Selective radioligands have been developed for mapping these receptors using single photon emission computed tomography (SPECT) and positron emission tomography (PET). A number of clinical studies have identified the changes in ACh receptors (AChRs) in aging, neurodegenerative diseases, and many other types of neurological disorder. In addition, a number of clinical studies elucidated the mechanisms of action of pharmaceuticals and tobacco addiction. This chapter presents a summary of the research regarding the clinical brain imaging of AChRs by SPECT and PET, and discusses the potential usefulness of these techniques in the pathofunctional analysis of CNS diseases.

View all citing articles on Scopus

View full text

Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: Forebrain

Abstract

Pharmac. Biochem. Behav.

Neurobiol. Aging

Brain Res.

Brain Res. Bull.

Brain Res.

Brain Res. Bull.

Lancet

Brain Res.

Neuroscience

Brain Res.

Brain Res.

Brain Res.

Lancet

Brain Res.

Neurosci. Lett.

Brain Res.

Brain Res. Rev.

Brain Res.

Brain Res.

Neurosci. Lett.

Life Sci.

Neurosci. Lett.

Brain Res.

Brain Res.

Brain Res.

Brain Res.

Brain Res.

Int. Rev. Neurobiol.

Expl Neurol.

Brain Res.

Neuroscience

Brain Res.

Trends Neurosci.

Trends Neurosci.

Neuroscience

Brain Res.

Life Sci.

Brain Res.

Neuroscience

Neuroscience

Neuroscience

Brain Res.

Neurosci. Lett.

Brain Res.

Regional distribution of choline acetyltransferase in the human brain: changes in Huntington's chorea

J. Neurol. Neurosurg. Psychiat.

Distribution of cholinergic neurons in rat brain: demonstrated by the immunocytochemical localization of choline acetyltransferase

J. comp. Neurol.

Physostigmine and recent memory: effects in young and aged nonhuman primates

Science

The cholinergic hypothesis of geriatric memory dysfunction

Science

Efficacy of oral physostigmine in primary degenerative dementia. A double-blind study of response to different dose level

Psychopharmacology

The binding of agonists to brain muscarinic receptors

Molec. Pharmac.